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The term "rheumatoid factor" has been applied to the protein component of 
serum which is responsible for a  group of agglutination and precipitation reac- 
tions,  some of which have been employed as diagnostic procedures in rheuma- 
toid arthritis  (1, 2). In these reactions this factor interacts with antibody coat- 
ing red cells or organisms, with antibody in antigen-antibody precipitates,  (3) 
or  with  gamma  globulin  itself  (4).  Previous  studies  from this  laboratory  (5) 
have indicated  that direct precipitation  of the rheumatoid factor with gamma 
globulin takes place only if the gamma globulin is in an aggregated form. In ad- 
dition,  some interaction with low molecular weight gamma globulin appears to 
occur, since the factor in serum and plasma is found as a  soluble complex with 
7  S gamma globulin  (5,  6). 
Analytical studies have indicated that the rheumatoid factor is a  typical 19 S 
gamma globulin with chemical, physical, and immunological properties closely 
akin to those of known 19 S antibodies  (7,  5).  These observations suggest that 
it is an antibody. On the other hand,  certain analogies to the behavior of com- 
plement suggest that it might be an unusual type of complement-like material. 
It is clear, however, that it is not one of the known components of the comple- 
ment-properdin  system (8,  3, 9). 
The present  studies  were undertaken  to characterize further  the  antibodies 
and  gamma  globulin  with  which  the  rheumatoid  factor  will  interact.  Reac- 
tions with  soluble and insoluble  aggregates of gamma globulin were  observed, 
and  evidence  was  obtained  for a  reaction  with  a  variety  of soluble  antigen- 
antibody complexes. 
Material and Methods 
Rheumatoid Factor.--The sera employed in this  study were obtained  from four different 
patients who had long standing  rheumatoid  arthritis  and  concentrations  of 100 to 300 rag. 
per cent 22 S rheumatoid factor complex in their sera (5). 
Isolated  rheumatoid  factor was prepared  by density  gradient  zone centrifugation  (7,  5) 
either  from  euglobulin fractions  or from  dissolved precipitates  of rheumatoid  factor with 
aggregated  gamma  globulin. The  precipitates  were dissolved in  glycine-HC1 buffer,  pH 
3.0, and  the 19 S rheumatoid  factor was isolated from the sucrose density gradient  solution 
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as described in  the section on ultracentrifugation. Such preparations consisted of at  least 
90 per cent 19 S material. The preparations made from eugtobulin fractions contained some 
normal 19 S proteins. Fig. 1 illustrates the ultracentrifugal pattern of a  typical preparation 
used in this study. These preparations at a concentration of 1 mg./ml, reacted at dilutions of 
1/640 to  1/5120  in the sheep cell  test, and at  dilutions of 1/5120  to  1/20,480  in the latex 
fixation test. 
The  various  serologic  tests were carried  out  as  described previously  (5).  Serial  2-fold 
dilutions were made, and  the number of the last tube giving a  positive result was listed. 
The inhibition of the sheep cell agglutination reaction was measured by adding 0.5  ml. of 
inhibiting protein to 0.5  ml. of active rheumatoid serum,  (usually diluted  1/10),  and then 
carrying out serial dilutions of this mixture for the reactions with sensitized sheep cells. As 
controls, 0.5 ml. portions of saline in place of protein solutions were added to the same rheu- 
matoid serum. 
Antisera.--Rabbit  antisera  to  human  serum  albu- 
min and  to  7 S  gamma globulin were obtained from 
animals  immunized  subcutaneously with  the  antigen 
in  Freund's adjuvant. Antiserum to  crystalline oval- 
bumin from rabbits immunized  by  repeated intrave- 
nous injections of antigen was kindly supplied by Dr. 
Curtis  Williams.  Horse  antiserum  to  pneumococcus 
type III was obtained from Dr. Maclyn McCarty. 
The antipneumococcal and antiovalbumin sera were 
used  in  the  unfractionated  state. In the case of anti- 
sera  to  human  serum  albumin  and  human  gamma 
globulin, the gamma globulin fractions were separated 
FIG.  1.  Ultracentrifugal  pat-  by zone electrophoresis in starch using barbital  buffer 
tern of isolated rheumatoid factor,  pH 8.6, I'/2 0.1  by methods previously described (10). 
The corrected sedimentation rate  After elution with phosphate buffer pH 7.6, 1"/2 0.1 or 
was 18.8 S.  0.15 N saline the fractions were concentrated by ultra- 
filtration. 
Antigens.--Hurnan  7 S gamma  globulin was a  Lederle fraction II preparation, lot  No. 
C440,  demonstrated to be free of 19 S gamma globulin. Ovalbumin was 2X  recrystallized 
material  obtained from  Worthington Laboratories. Human  serum  albumin was  a  Squibb 
fraction V preparation. Pneumococcus type III polysaccharide was obtained from Dr. Walther 
Goebel. 
Preclpitin Reactions.--These  were performed in duplicate using 0.05 to 0.1 ml. of antiserum 
or antiserum gamma globulin. After addition of antigen, the mixture was brought to a constant 
final  volume of 0.55  cc. with phosphate buffer or saline.  After 1 hour at room temperature 
and 24 hours at 4°C.,  the precipitates were washed twice with saline or buffer at 4°C.  with 
centrifugation at  1,000 g  for 30  minutes between washes. Protein in  the precipitates was 
measured by the modified Folin-Ciocalteu method (11). 
Two parallel precipitin reactions were set up.  After 1 hour at  room temperature, 0.05 
ml. of a  particular rheumatoid factor preparation was added to each tube of one set, and 
0.05 ml. of saline or buffer was added to the control group. Precipitates were measured after 
24  hours at  4°C.  No  significant amounts of precipitation occurred in  control tubes with 
antigen alone and antibody alone. A small amount of precipitate formed in control tubes con- 
taining rheumatoid factor alone, rheumatoid factor plus antigen, and rheumatoid factor plus 
antibody. The highest optical density value of these controls was subtracted from the optical 
density  values  for  each  antigen  concentration before calculating  the  amount  of  protein 
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Preparation of Soluble Antigen-Antibody Complexes.--From 8 to 20X equivalence amounts 
of antigen were combined with electrophoretieally isolated gamma globulin containing anti- 
body, allowed to react for 1 hour at room temperature, and were then placed at 4°C. for 24 
hours to 7 days.  Before use, these preparations were centrifuged at 6000 g for 1 hour in a 
Spinco model L ultracentrifuge. 
Preparation of Altered Gamma Globulin.--Ten  rag. of Lederle fraction II gamma globulin 
was placed in i  to 2 ml. of tris buffer, 0.1 ~s, pH 8, which was made 6 M in urea and 0.1 ~  in 
mereaptoethanol. After 1 hour at room temperature, this preparation was dialyzed against 
one liter of tris buffer at 4°C. for 24 hours. In certain preparations the dialysis solution was 
made 0.02 •  in iodacetamide. 
In similar fashion preparations of gamma globulin were made using 3  ~  guanidine HC1 
alone, 6 M urea alone, and 0.1 M mercaptoethanol alone. Heated preparations were made by 
exposing a  10 mg./ml, solution to 63°C. for 10 minutes. 
Solid gamma globulin was prepared by heating Lederle fraction II gamma globulin at a 
concentration of 40 mg./ml, in isotonic saline to approximately 75°C.  at which temperature 
most of the gamma globulin precipitated. This was then washed 3 times with saline, and finally 
suspended in an equal volume of saline. Two additions of 0.35 ml. of such a  suspension to 
0.5 ml. of serum were used in the experiments shown in Table IV. 
Ultracentrifugation.--Density  gradient  zone  centrifugation was  carried  out  in  a  Spinco 
model L machine employing the swinging bucket rotor. Protein fractions, (0.5 to 1 ml., 5 to l0 
mg./ml.), were layered over a sucrose density gradient containing 37 per cent sucrose at the 
bottom and l0 per cent sucrose at the top. Droplet formation was minimized by slight stirring 
of the protein solution with the sucrose below it, and by beginning ultracentrifugation im- 
mediately after layering. Ultracentrifugation for 15 hours at ll0,000 g resulted in sedimenta- 
tion of  19 S  class proteins to  a  position approximately three-fourths of the distance down 
the tube; 7 S class proteins remained in the upper portion of the tube. Isolation of the frac- 
tions from the density gradient following centrifugation was carried out in two ways; either 
by simple rembval of samples at various levels by means of a  stabilized capillary pipette, or 
by making a  small hole in the bottom of the plastic centrifuge tube and  allowing drops to 
collect in a fraction collector. In those eases in which aggregated gamma globulin was packed 
on the bottom of the tube, the hole was made in the wall just above this level Protein analy- 
ses on these fractions furnished curves of the distribution of the separated proteins. The chief 
limitation of  the procedure was  slight contamination of upper fractions.  However,  it was 
satisfactory for the isolation and  complete recovery of  the  19 S  rheumatoid factor.  Final 
identification of these proteins was made by analytical ultracentrifugation, or by immuno- 
logical methods (5,  12). Shorter periods of ultracentrifugation were sometimes utilized for the 
characterization of  the  size  of  gamma  globulin aggregates.  Analytical ultracentrifugation 
was carried out as previously described (5). 
RESULTS 
I.  Reaction of Rheumatoid Factor with Soluble Antigen-Antibody Complexes.- 
In preliminary experiments, rheumatoid serum and normal serum were added 
to  a  gamma  globulin-rabbit  anti-human  gamma  globulin  system in antigen 
excess. Rheumatoid serum caused more precipitation than comparable amounts 
of normal serum. Purified 19 S rheumatoid factor was used in all subsequent 
experiments because the different complement and gamma globulin contents 
in whole sera made quantitation difficult. 
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preparation containing 3.2 mg. protein/ml, to each tube of an ovalbumin-rabbit 
anti-ovalbumin system. There was a considerable increase in nitrogen values of 
the precipitates compared to those of the control series. This was most marked 
at equivalence and in antigen excess. 
This procedure did not distinguish binding of rheumatoid factor by solid precipitates from 
binding  to soluble antigen-antibody  complexes. The supernates  therefore were removed as 
quantitatively  as possible from each tube in the control series. To each supernate  0.05 ml. 
of the' same rheumatoid factor preparation  was added. After 24 hours at 4°C., the amount of 
precipitate  was measured. In Fig. 2, the amount of nitrogen in these precipitates  is plotted 
against the antigen concentration to which each supernate corresponds. Because these points 
do not represent a true precipitin curve, no line is drawn connecting them. 
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Fig. 2. The effect of rheumatoid factor on the ovalbumin-rabbit  anti-ovalbumin predpitin 
system. O--O control precipitin reaction;  •--•-  precipitin reaction with added rheumatoid 
factor; •  supernates from control curve with added rheumatoid factor. 
Corresponding  to  the  absence  of  soluble  antigen-antibody  complexes  in 
antibody excess supernates, almost no precipitate was present in this zone. The 
precipitate was maximal at a point in antigen excess approximately 2 X  equiva- 
lence, and the values gradually fell in the region of increasing antigen excess. 
When the difference between the precipitated  nitrogen of the control curve, 
and that of the curve with added rheumatoid factor is compared to the amount 
of nitrogen precipitated when rheumatoid factor is added to the supernates,  it 
is seen that the values are not the same (Fig. 2). This difference can be explained 
in part by the presence of antigen-antibody precipitates  in the first case, and 
their absence in the second. Another factor that may have been responsible is 
the time of addition of rheumatoid factor. In the first case rheumatoid factor 
was added 1 hour after mixture of antigen and antibody, and in the second case 
it was added to 24 hour old relatively stable antigen-antibody complexes. 
A further check on the reactivity of soluble antigen-antibody complexes was made using 
8X  equivalence ovalbumln-anti-ovalbumin sohlble complexes,  freed  of possible suspended G. M. ]~DELMAN,  H. G. KUNKEL,  AND  E. C. ~RANKLIN  109 
particulate  material  by high speed centrifugation.  When these complexes were layered with 
rheumatoid  factor in  capillary  precipltin  tubes,  visible  precipitation  occurred  within  10 
minutes. Mixture of the soinble complexes with rheumatoid  factor in a test  tube led to the 
appearance of a stringy flocculant precipitate in 10 minutes. 
Similar effects were observed when rheumatoid factor was added in the rabbit anti-human 
albumin system  (Fig. 3). A rheumatoid  factor preparation  containing 0.81 mg. protein/mh 
was used in 0.05 mi. portions per tube. The effect of rheumatoid factor in this case was greater 
in antigen excess than at equivalence. When 0.05 ml. of the same rheumatoid  factor prepa- 
ration was added  to the supernates  of the control curve, maximal precipitation  of antigen- 
antibody complexes occurred at a point in antigen excess 5X equivalence. 
The  interaction  between  rheumatoid  factor  and  the  rabbit  anti-human 
gamma globulin system also was studied  (Fig.  4).  Electrophoretically isolated 
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Fro. 3.  The effect of rheumatoid  factor on the  rabbit  antl-human albumin  predpit/n 
reset.ion. O--O- control precipitin  reaction;  e--e  precipitin  reaction  with added  rheu- 
matoid  factor;  []..../7  precipitin  reaction  with added  rheumatoid  factor heated  at  56°C. 
for I hour. 
human gamma globulin which showed no reaction with rheumatoid factor was 
used in these experiments.  Certain difficulties arise in the interpretation of this 
precipitin system. Because rheumatoid factor is a  19 S gamma globulin, which 
reacts  with  antibody to gamma globulin in the zone of antibody excess,  this 
portion of the curve cannot be compared with preceding curves. In the region 
of antigen  excess, an exchange of rheumatoid factor with  7 S antigen gamma 
globulin in the complexes could occur. This seems improbable,  however, since 
the difference between  the  two curves was greater in the antigen  excess zone 
where exchange was less likely.  Finally,  a  minor component of antibodies  to 
19 S  gamma globulin might be present.  This di/ficulty was avoided by using 
antisera to 7 S gamma globulin which had no antibodies to 19 S gamma glob- 
ulin. It seems likely that interaction of rheumatoid factor with antibody com- 
plexes was involved in this system as in the others described above. 110  INTERACTION  O]? RHEUMATOID  FACTOR 
In Table I  the amount of nitrogen precipitated in the horse anti-pneumococ- 
cus  type  III system  is  compared to  the  values  obtained  when  0.05  ml,  of 
rheumatoid factor (0.9 mg./ml.) was added to the same precipitation system 
1 hour after mixture of antigen and antibody. No tendency to increased pre- 
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FIG. 4.  The effect of rheumatoid factor on the rabbit anti-human gamma globulin pre- 
cipitin reaction. O--O control precipitin reaction: O--O precipitin reaction with added 
rheumatoid factor. 
TABLE I 
Nitrogen Precipitated in Horse Anti-Pneumococcus Type III Prec~pitin Reaction, with and 
without Rheumatoid Factor 
Antigen  Ppt'd.  N control  Ppt'd.  N control +RF  Ppt'd.  N control  super-  hates  + RF 
~g. 
0.4 
0.8 
1.6 
3.3 
6.6 
13.1 
26.2 
52.5 
105.0 
210.0 
8.8 
10.1 
9.9 
9.0 
9.0 
8.3 
8.0 
6.9 
5.6 
3.4 
~g. 
8.0 
9.0 
9.0 
9.3 
8,2 
7.9 
7.1 
5.9 
5.4 
3.5 
0 
0 
cipitation  was  seen.  The  same  amounts  of rheumatoid  factor  added  to  the 
supernates of the control series  yielded no precipitate greater  than that of the 
corresponding control containing rheumatoid factor alone. 
II,  Factors  Involved  in  the  Reaction  with  Antigen-Antibody  Complexes.- 
Equal amounts of unheated rheumatoid factor, and rheumatoid factor heated 
to 56°C. for 1 hour were added to separate tubes of the anti-human albumin G.  M.  EDELMAN',  H.  G.  KUNKEL,  AND  E.  C.  FRANKLIN  III 
system. The capacity of rheumatoid factor to precipitate antigen-antibody com- 
plexes was only slightly reduced by heating (Fig.  3).  This is in contrast to 
effects observed with complement (14).  The presence of 3  X  10  -3 •  ethylene 
dinitrilotetraacetic acid did not influence the interaction between rheumatoid 
factor and soluble complexes. 
Prolonging the reaction time of the antigen-antibody system had little effect. 
Duplicate tubes, with and without rheumatoid factor were prepared, using the 
rabbit anti-human albumin system. Mter 7 days at 4°C., precipitate nitrogen 
values were compared to values of tubes prepared in the same way and read 
at 24 hours. There was no significant difference. In most instances the rheuma- 
toid factor shortened the appearance time of antigen-antibody precipitates. 
The  amount of precipitate obtained when varying amounts of a  solution 
containing a  given  antigen-antibody complex  were  mixed  with  rheumatoid 
TABLE II 
Variation in Nitrogen Precipitated by Rheumatoid Factor with  Varying A mounts of Protein 
from the Human Gamma Globulin-Rabbit Anti-Human Gamma Globulin System  at 
gOX Equivalence 
Protein  Ppt'd 
N  N 
/tg. 
24O 
160 
120 
80 
ttg- 
5.0 
3.4 
2.5 
2.2 
factor is shown in Table IL The solution was diluted with buffer to the values 
for total protein nitrogen content shown. A  0.4 ml. volume of each dilution 
was mixed with 0.05 ml. of a rheumatoid factor preparation (1.4 mg./ml.), the 
mixture was stored for 24 hours at 4°C., and precipitate nitrogen was deter- 
mined. An approximately linear relationship is shown between the amount of 
precipitate nitrogen and the amount of nitrogen in the solutions containing 
the antigen-antibody complexes. These experiments were difficult to interpret 
in view of the indeterminate amounts of reactive antigen-antibody complex 
in the solutions. Attempts to obtain complete precipitin curves using antigen- 
antibody complex as  "antigen" and  rheumatoid factor as  "antibody" were 
unsuccessful for technical reasons. 
III.  The Size of Reactive Complexes.--The minimum size of gamma globulin 
complexes with which rheumatoid factor will react and precipitate is difficult 
to determine. Several attempts were made to define a  range below which no 
precipitation with rheumatoid factor would occur, employing the method of 
density gradient centrifugation. 112  INTERACTION  O~F  RHEUMATOID  ]~ACTOR 
A solution containing 7 S gamma globulin-anti-gamma  globulin complexes  at 10X equiva- 
lence was layered over a sucrose  density gradient, and centrifuged at 110,000 g for 12 hours. 
Various layers were then tested for precipitation with rheumatoid factor, in capillary tubes 
and test tubes. No reaction was observed  with layers below a sedimentation rate of approxi- 
mately 20 S, and the main reaction was with fractions sedimenting more rapidly than 20 S. 
Another experiment  under slightly different conditions  also indicated that large size antigen- 
antibody complexes  were involved and that there was no reaction at  the level expected 
for limiting complexes  of bivalent antibodies. 
IV. Reaction of Rheumatoid Factor with Gamma Globulin Aggregates.--It  was 
previously established (5) that heating gamma globulin from 62-65°C. for 10 
minutes produced gamma globulin solutions that reacted strongly with rheuma- 
toid sera in a  direct precipitin reaction. Evidence was obtained that  the in- 
creased reactivity was due to aggregates of gamma globulin. Other procedures, 
such as treatment with alkali, and euglobulin formation, as well as simple ag- 
ing,  also  produced reactive gamma  globulin.  The possibility arose  that  the 
more classical methods of unfolding and denaturing proteins might produce 
more reactive gamma globulin, and perhaps some material of low molecular 
weight that would cause precipitation. 
Table III illustrates results with some of the methods tested. The combina- 
tion of urea and mercaptoethanol produced extremely active preparations, in 
some instances  more active than  the heating procedures.  This  activity was 
largely  blocked  by  iodacetamide,  which  stops  disulfide  bridge  formation. 
Guanidine also produced very active preparations. A second method of testing 
these 7-globulin preparations was by their inhibitory capacity in the sensitized 
sheep cell agglutination  reaction.  Fraction II 7-globulin is known to inhibit 
this reaction strongly. However it was found in the present study that dec- 
trophoretically isolated 7-globulin showed little or no inhibitory capacity. Fol- 
lowing treatment with urea and mercaptoethanol or heating to 63°C. a marked 
increase in inhibitory activity was observed (Table III). 
Zone ultracentrifugation in a sucrose density gradient demonstrated that the 
activity in each of these preparations of human gamma globulin was due pri- 
marily to aggregated material with an s rate greater than 20 S (Table IV). No 
precipitating and little or no sheep cell inhibiting activity was encountered with 
material with an s rate of 7 S--the s rate of the major portion of the gamma 
globulin even after these procedures. Concentrated preparations of aggregated 
gamma globulin of considerably higher activity per unit of nitrogen were read- 
ily obtained by short periods of ultracentrifugation either with or without the 
density gradient. 
Rabbit gamma globulin could also be made reactive by the urea-mercapto- 
ethanol procedure, and less consistently by the heating method. The precipifin 
activity with  rheumatoid  sera  was  always  weaker  than  for human  gamma 
globulin. Inhibition of the sheep cell reaction, however, was greater than for 
human gamma globulin. Gamma globulin freshly prepared from rabbit serum G.  M.  EDELMAN,  H.  G.  KUNKEL~  AND  ]E.  C.  FRANKLIN  113 
by  electrophoresis  always  showed  considerable  inhibition  of  the  sheep  cell 
reaction, in contrast to similar preparations of human gamma globulin. Rabbit 
TABLE IH 
Effect of Various Procedures on the Reactivity of Human Gamma Globulin with Rheumatoid Sera 
Human "r-globulin* 10 mg./ml.  Precipitin reaction with various sera 
Treatment  Normal 
H.K. 
Intact 
Heated 63°... 
Urea. 
Mercaptoethanol. 
Urea +  mercaptoethanol... 
Urea +  mercaptoethanol + 
iodacetamide. 
Guanidine. 
Rheumatoid  Rheumatoid 
E.P.  M.S. 
0  0 
++++  ++++ 
+  Tr 
++ 
++++  ++++ 
Tr  Tr 
++++  ++++ 
Sheep cell inhibition~ 
Electropho-  Electropho- 
retie "r-globu-  retie ~-globu- 
lin I  lin II 
1  0 
6  6 
6  7 
* Led Fr. II No. C 440. 
:~ Total inhibition would be 7 (expressed as tube No. of serial dilutions). 
TABLE IV 
Activity of Various  Fractions  of Gamma  Globulin, Separated  by Zone  Ultracentrifugation,  in 
Precipitin  Test with Rheumatoid  Factor, and  in Inhibition  of the Sensitized  Sheep Cdl 
Agglutination  Reaction 
Ft. 
No. 
I 
II§ 
III 
IV 
v§ 
Approxi- 
mate 
s rate 
Precipitin test* 
~,-globulin preparations 
Hunlan 
Fr. II 
63 ° 
0 
7S  0 
0 
19 S  0 
>20 S  ++++i 
Human  Rabbit 
Fr. II  urea 
urea mer-  mercap- 
eapto-  toethanol  ethanol 
0  0 
0  0 
0  0 
0  0 
++++  ++ 
Hurrah 
Fr. II. 
Sheep cell inhibition~ 
q~-globulin preparations 
Hmnan 
Fr. II 
63  ° 
Human 
Fr. II urea 
mercapto- 
ethanol 
Rabbit 
electro- 
phoretic 
"r-globulin 
Rabbit 
electro° 
phoretic 
7-globulin 
urea 
mercapto- 
ethanol 
* Carried out with rheumatoid serum E.P. 
Total inhibition =  7. 
§ Fractions II and V were usually tested at a concentration of 5 mg./ml. 
gamma globulin both in the native state and in the treated preparations, also 
showed significant inhibitory activity in the 7 S fraction as well as in the high 
molecular  weight  fractions  (Table  IV).  Relatively  large  concentrations  of 
gamma globulin were necessary to bring out these effects, (at least 3 mg./ml.). 114  INTERACTION OF  RHEUMATOID FACTOR 
Inhibition  by  aggregated  rabbit  and  human  gamma  globulin,  on  the  other 
hand, occurred at far lower concentrations. 
V.  Adsorption  on  Solid  Gamma  Globulin.--Human  gamma  globulin  which 
was precipitated  and denatured by heating,  was found to adsorb the rheuma- 
toid factor from various  sera.  Such gamma  globulin preparations  were com- 
pletely insoluble, and did not go back into solution in different aqueous buffers. 
Two additions of solid material to rheumatoid serum usually removed much of 
the  activity in the  latex fixation,  precipitation,  and  sensitized  sheep  cell  ag- 
glutination tests  (Table V). In some instances,  slight activity remained in the 
serum, and the extent of removal of activity was partly dependent on the solid 
TABLE V 
Activity of Various Rheumatoid Sera before and after Adsorption with Solid Gamma Globulin; 
and Activity of Acid Eluates 
Serum E.P. 
Before ................ 
After ................ 
Serum R.P. 
Before ............... 
After ................ 
Serum P.R. 
Before ............... 
After ................ 
Eluate E.P. 
0.4 mg./ml  ........... 
Eluate P.R. 
0.6 mg./ml  ........... 
Sensitized sheep  Precipitin reaction  Latex flxation*  cell agglutination* 
++++ 
0 
++++ 
+ 
++++ 
0 
++++ 
++++ 
9 
0 
9 
5 
13 
5 
7 
9 
8 
0 
9 
2 
12 
0 
7 
7 
* Numbers  refer to the positive  numbers  in serial dilutions starting with 1/20 dilution 
gamma globulin employed. The activity which was removed from serum could 
be readily  eluted  from the  gamma globulin,  following washing,  by means  of 
urea  or  acid  buffers.  Dialysis  to  remove  urea  or  acid  usually  caused  some 
precipitation,  but  highly  active  preparations  could  still  be  recovered.  Ana- 
lyrical ultracentrifugation  indicated  that  these  preparations  consisted  of ap- 
proximately 70 per cent 19 S material. 
VI.  Composition  of  the  Rheumatoid  Factor-Altered  Gamma  Globulin  Pre- 
cipitate.--Further  evidence  that  aggregated gamma globulin was involved in 
the  precipitation  reactions  with  rheumatoid  factor was  obtained  from ultra- 
centrifugal  analyses  of the  composition  of the  specific precipitates.  The pre- 
cipitates made from serum, following thorough washing with saline,  dissolved 
readily in glycine-HCl buffers as well as in 6 M urea. Analytical ultracentrifugal O.  M.  EDELMAN~ H.  O.  KUNKEL,  AND  E.  C.  ]~RANKLIN  115 
analyses of the dissolved precipitates showed three major peaks. The details of 
these  investigations  will  be  published  separately  (13),  but  in  general  these 
peaks represented three classes of proteins--one group with an s rate of ap- 
proximately 7 S, a second with a sharp peak of approximately 19 S, and a third 
heterogeneous group of considerably higher s rate but with the major portion 
sedimenting at approximately 40 S.  The latter group represented the aggre- 
gates used to obtain the precipitate. 
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Fro. 5.  Curves  representing  protein  concentration  in  different  fractions  of  dissolved 
specific precipitates of rheumatoid factor separated by zone centrifugation. The upper curve 
of precipitates from whole serum shows a  7 S peak in tube 11; the lower curve from isolated 
rheumatoid factor shows very little 7 S protein. The activity of the fractions in the gamma 
globulin predpitin test is indicated above the curves and shows the position of the rheumatoid 
factor. The peak in tube 1 represents aggregated gamma globulin. 
Density gradient ultracentrifugation gave similar results.  Fig.  5 shows the 
results  of a  typical experiment in the density gradient. The heavier fractions 
are in the early tube numbers. The peak in tube I was the pellet that contained 
all materials with an s rate greater than approximately 30 S. The peak in tube 
6  represented the active 19 S rheumatoid factor  as proven both by activity 
analyses, as well as by examination in the analytical  ultracentrifuge (Fig.  1). 
This was the standard procedure for isolating the rheumatoid factor. The peak 
in tube 11 had an s rate of approximately 7 S. This peak was barely detectable 
in  the lower curve which  represents  a  precipitate obtained from previously 
isolated  rheumatoid factor,  and  was  only evident when the  precipitate  was 
made from whole serum, or from euglobnlin fractions. These results suggested 
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globulin was added to whole serum. The ratio of aggregated  gamma globulin 
to rheumatoid factor was quite variable in these experiments. 
DISCUSSION 
The present observations  on the interaction of the rheumatoid factor with 
antigen-antibody complexes throughout the region of antigen excess, extend 
the observations  of Vaughan (3)  on the adsorption of rheumatoid factor  to 
antigen-antibody precipitates.  Evidence for interaction with soluble complexes 
in the region of far antigen excess was obtained.  In this region the proportion 
of "limiting complexes" should  be high.  All the evidence obtained, however, 
indicated that only large complexes with an s rate greater than 20 S were in- 
volved. These complexes appeared similar in size to the soluble aggregates  of 
gamma globulin which precipitate with rheumatoid factor. 
The binding of rheumatoid factor to  soluble  antigen-antibody complexes 
appeared to depend upon many variables.  Among these were the concentra- 
tion and purity of the rheumatoid factor, the size of the antigen-antibody com- 
plexes, the proportions  of reactive  constituents, and the time of addition of 
rheumatoid factor to the precipitin  system. No reaction between  rheumatoid 
factor and the horse anti-pneumococcal system was observed. This is in keeping 
with the finding that horse anti-egg albumin precipitates  did not bind rheuma- 
toid factor (3). The reaction with human soluble antigen-antibody complexes 
has not been investigated, but such a process may be important in detailing 
the role  of rheumatoid factor in some of the manifestations of rheumatoid 
arthritis. 
In some respects,  the behavior of rheumatoid factor with soluble antigen- 
antibody complexes and immune precipitates is  similar  to the reported be- 
havior of complement  (14, 15). Weigle and Maurer (16), in a  study of the 
binding of complement to soluble rabbit antigen-antibody complexes in antigen 
excess, propose  two hypotheses to  account for this  effect.  (a)  Complement 
fixed to complexes leads to an increase in weight, or neutralization of charge, 
with subsequent precipitation.  (b)  Complement  is multivalent to antigen or 
antibody, and could  link complexes together to form precipitates.  Whether 
rheumatoid factor interacts with antigen-antibody complexes in either of these 
ways is not known. Hill and Osler (17) noted that antibody which aggregates 
and flocculates readily, shows the greatest complement-fixing potency. Fur- 
thermore,  Olhagen (18) showed that aggregated gamma globulin is responsible 
for anticomplementary effects. This suggests the possibility  of an interaction 
of complement  with gamma globulin  aggregates  similar  to that noted with 
rheumatoid factor. Further studies of complement  in these directions  appear 
indicated. 
In the past, some authors (19, 20)  have suggested that rheumatoid factor 
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performed experiments to show that rheumatoid factor cannot be identified 
with any of the known components. It is known (14) that heating complement 
to 56 ° destroys its capacity to fix to antigen-antibody complexes. Such heating 
has only slight effects on binding of rheumatoid factor to  antigen-antibody 
complexes or to immune precipitates. 
Soluble  aggregates  of  gamma  globulin  which  precipitated  readily  with 
rheumatoid factor could be prepared  in numerous ways, such as heating to 
62-65°C.,  treatment with the combination of urea and mercaptoethanol, and 
treatment with guanidine. Short periods of ultracentrifugation furnished con- 
centrated preparations of aggregated gamma globulin that were considerably 
more reactive per unit of nitrogen.  No  evidence was  obtained for any pre- 
cipitating activity or significant inhibition activity in the sensitized sheep cell 
test of non-aggregated human gamma globulin of the native 7 S class.  This is 
in  line  with  the  lack  of  reaction  with  antigen-antibody complexes  of  low 
molecular weight.  Similar observations on the important role of aggregated 
gamma globulin have been made by Christian and Ragan (21). 
Vaughan and Waller (22)  have recently obtained evidence from ultrafiltra- 
tion experiments  that  low molecular weight human  gamma globulin  shows 
inhibitory activity in  the  sensitized  red  cell  system  in  which  red  cells  are 
coated with human Rh antibody. The present observations indicate that 7 S 
rabbit gamma globulin inhibits a similar system where red cells are coated with 
rabbit antibody. It appears that species specificity is involved, and is brought 
out in the reaction with native low molecular weight gamma globulins. 
Considerable data have  been  accumulated  (5,  6)  demonstrating  that  the 
rheumatoid factor is a  19 S gamma globulin which exists in serum and plasma 
in a soluble state complexed to 7 S gamma globulin, but the question of whether 
the latter represents non-specific gamma globulin, or a  specific  component in 
this spectrum of proteins, is not entirely answered. Some preliminary experi- 
ments have indicated that isolated 19 S rheumatoid factor combines with nor- 
mal fraction II gamma globulin to give a  soluble complex, but this has not 
always been the case. It has been more readily demonstrated that native com- 
plex which is dissociated in urea recombines following removal of the urea. 
These results demonstrate further that an affinity exists between rheumatoid 
factor  and  low molecular  weight gamma globulin,  although  aggregates  are 
necessary for precipitation. 
Little difference is detectable between the reactions of isolated 19 S rheuma- 
toid factor and the native comptexed rheumatoid factor. Aggregated gamma 
globulin precipitates with both.  In the case of the native rheumatoid factor 
the entire complex appears to precipitate with the aggregates, suggesting that 
the aggregates do not displace the 7 S gamma globulin that already is present 
but interact at a  different site on the 19 S rheumatoid factor molecule. Evi- 
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the  ultracentrifuge of  urea-  and  acid-dissolved  precipitates  of  rheumatoid 
factor and aggregated  gamma globulin. This has been confirmed through the 
use of pl-labelled aggregated  gamma globulin (13), and it appears  clear that 
considerable  7  S  gamma  globulin  is  precipitated  in  the  reaction  between 
rheumatoid factor complex and aggregated  gamma globulin.  Some evidence 
has also  been  obtained of interchange between 7 S gamma globulin  in the 
rheumatoid factor complex  and labelled  7  S gamma globulin  added to  the 
system. Just how 7 S gamma globulin can inhibit the rheumatoid factor reac- 
tions, when the factor is already coated with 7 S gamma globulin in the native 
complex, remains unclear. 
The present observations  add little to settle the question of whether the 
rheumatoid factor is  an antibody to gamma globulin,  or a  complement-like 
substance.  The reactivity with rabbit  gamma globulin,  which  is  in general 
weaker  than with human gamma globulin,  is  not against the antibody hy- 
pothesis.  Maurer  (23) has  demonstrated cross-reaction  between rabbit and 
human gamma globulin. The additional possibility  raised  by the present ex- 
periments is that the rheumatoid factor might represent an antibody to anti- 
gen-antibody complexes, perhaps  related to the type proposed  by Najjar and 
Fisher (24). If this is the case, gamma globulin is only part of the antigen which 
then gives rise to a group of secondary antibodies  which will react with gamma 
globulin. A search for the other portion of the hypothetical antigen-antibody 
complex  giving rise  to  the rheumatoid  factor might yield considerable  fur- 
ther  information. 
SUMMARY 
The effect of highly purified rheumatoid factor on the precipitin  reactions of 
various  antigen-antibody systems was  determined. The amount of nitrogen 
precipitated was increased over a broad range when the factor was added to 
ovalbumin, human albumin, or human gamma globulin, and the corresponding 
rabbit antibodies. In the zone of antigen excess, soluble antigen-antibody com- 
plexes were precipitated by rheumatoid factor. 
Soluble aggregates of human and rabbit gamma globulin, produced by heat- 
ing at 63°C., treatment with urea plus  mercaptoethanol or treatment with 
guanldine, also precipitated with rheumatoid factor. Ultracentrifugal analysis 
of dissolved  specific precipitates showed  the presence  of aggregated  gamma 
globulin. The sedimentation rate of reactive aggregates was greater than 20 S, 
and concentrated preparations free of the non-reactive  7 S gamma globulin 
could be prepared by various  procedures of zone centrifugation.  These aggre- 
gates showed a high inhibitory capacity in the sensitized sheep cell agglutina- 
tion reaction. 
Solid gamma globulin, prepared  by heat denaturation, also selectively  ad- 
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various precipitation and  agglutination  reactions.  Elution  of highly purified 
active preparations from the solid gamma globulin could be carried out  with 
urea or acid buffers. 
Evidence  for  interaction  between  rheumatoid  factor  and  low  molecular 
weight gamma globulin without precipitation,  was also obtained.  This inter- 
action appears to occur in the circulation of patients with rheumatoid arthritis. 
The question of whether the rheumatoid factor represents an antibody to 
gamma globulin was discussed. Points of similarity to the behavior of comple- 
ment also were cited. 
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